SLAB — Silicon Laboratories Balance Sheet
0.000.00%
- $6.81bn
- $6.36bn
- $784.76m
- 82
- 15
- 91
- 68
Annual balance sheet for Silicon Laboratories, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.
2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | 2026 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,192 | 2,039 | 439 | 382 | 444 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 71.4 | 98.3 | 29.3 | 54.5 | 64.5 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,461 | 2,239 | 738 | 602 | 674 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 177 | 174 | 173 | 154 | 129 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,169 | 2,958 | 1,443 | 1,223 | 1,269 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 186 | 669 | 164 | 97.9 | 144 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 764 | 746 | 234 | 143 | 175 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,405 | 2,212 | 1,209 | 1,080 | 1,094 |
| Total Liabilities & Shareholders' Equity | 2,169 | 2,958 | 1,443 | 1,223 | 1,269 |
| Total Common Shares Outstanding |